News
Q1 2025 Management View CEO Nikhil Lalwani highlighted a strong start to 2025, marked by record revenue, adjusted EBITDA, and ...
18h
Stocktwits on MSNANI Pharma Reports Upbeat Q1 Earnings, Revises Full-Year Outlook: Retail’s PleasedShares of ANI Pharmaceuticals, Inc. (ANIP) were in the spotlight on Friday after the company reported upbeat earnings and ...
Justice Bhuyan reportedly remarked that it is not the court's role to instruct the media to remove content, highlighting that ...
Ooops... Something went wrong while loading this page.
New Delhi: The Supreme Court on Friday said it is not the duty of the court to tell the media: delete this, take that down, ...
Increased 2025 guidance with expected net revenues of $768.0 million to $793.0 million, adjusted non-GAAP EBITDA of $195.0 ...
ANI expects full-year earnings in the range of $6.27 to $6.62 per share, with revenue in the range of $768 million to $793 million. ANI shares have climbed 29% since the beginning of the year. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results